Table of Contents Author Guidelines Submit a Manuscript
Tuberculosis Research and Treatment
Volume 2011, Article ID 239042, 9 pages
http://dx.doi.org/10.1155/2011/239042
Research Article

Mycobacterium tuberculosis Complex Genotype Diversity and Drug Resistance Profiles in a Pediatric Population in Mexico

1Department of Infectious Diseases, Instituto Nacional de Pediatría, Mexico City, Mexico
2Instituto Mexicano del Seguro Social Foundation, Mexico City, Mexico
3Subdivision of Medical Research, Instituto Nacional de Pediatría, Mexico City, DF, Mexico
4Programa de Inmunología Molecular Microbiana, Departamento de Microbiología y Parasitología, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, Mexico
5Department of Micobacteriology, Instituto De Diagnóstico y Referencia de Epidemiológicos, Secretaria de Salud, Mexico City, Mexico
6WHO Supranational Tuberculosis Reference Laboratory, Institut Pasteur de la Guadeloupe, Abymes, France

Received 17 March 2011; Accepted 22 May 2011

Academic Editor: Prasit Palittapongarnpim

Copyright © 2011 Mercedes Macías Parra et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Dye, S. Scheele, P. Dolin, V. Pathania, and M. C. Raviglione, “Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project,” The Journal of the American Medical Association, vol. 282, no. 7, pp. 677–686, 1999. View at Google Scholar
  2. P. Glaziou, K. Floyd, and M. Raviglione, “Global Burden and Epidemiology of Tuberculosis,” Clinics in Chest Medicine, vol. 30, no. 4, pp. 621–636, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. The World Health Organization, “Anti-tuberculosis drug resistance in the world—Fourth Global report,” The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance 2002–2007, WHO, Geneva, Switzerland, 2008, http://www.who.int/tb/publications/2008/drs_report4_26feb08.pdf. View at Google Scholar
  4. P. R. Donald and P. D. Van Helden, “The global burden of tuberculosis—combating drug resistance in difficult times,” New England Journal of Medicine, vol. 360, no. 23, pp. 2393–2395, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Walls and D. Shingadia, “Global epidemiology of paediatric tuberculosis,” Journal of Infection, vol. 48, no. 1, pp. 13–22, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Pablos-Méndez, M. C. Raviglione, A. Laszlo et al., “Global surveillance for antituberculosis-drug resistance, 1994-1997,” New England Journal of Medicine, vol. 338, no. 23, pp. 1641–1649, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. M. C. Raviglione, “The global plan to stop TB, 2006-2015,” International Journal of Tuberculosis and Lung Disease, vol. 10, no. 3, pp. 238–239, 2006. View at Google Scholar · View at Scopus
  8. Centers for Disease Control and Prevention, “The global plan to stop TB, 2006-2015: summary,” Morbidity and Mortality Weekly Report, vol. 81, pp. 86–88, 2006. View at Google Scholar · View at Scopus
  9. E. Nathanson, R. Gupta, P. Huamani et al., “Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiative,” International Journal of Tuberculosis and Lung Disease, vol. 8, no. 11, pp. 1382–1384, 2004. View at Google Scholar · View at Scopus
  10. G. Maartens and R. J. Wilkinson, “Tuberculosis,” Lancet, vol. 370, no. 9604, pp. 2030–2043, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Lobue, “Extensively drug-resistant tuberculosis,” Current Opinion in Infectious Diseases, vol. 22, no. 2, pp. 167–173, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. Centers for Disease Control and Prevention, “Extensively drug-resistant tuberculosis—United States, 1993–2006,” Morbidity and Mortality Weekly Report, vol. 56, no. 11, pp. 250–253, 2007. View at Google Scholar
  13. A. R. De Moura Valim, L. G. Possuelo, P. I. Cafrune et al., “Evaluation and genotyping of multidrug-resistant cases of tuberculosis in southern Brazil,” Microbial Drug Resistance, vol. 12, no. 3, pp. 186–191, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. F. A. Post, P. A. Willcox, B. Mathema et al., “Genetic polymorphism in Mycobacterium tuberculosis isolates from patients with chronic multidrug-resistant tuberculosis,” Journal of Infectious Diseases, vol. 190, no. 1, pp. 99–106, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. A. N. J. Malik and P. Godfrey-Faussett, “Effects of genetic variability of Mycobacterium tuberculosis strains on the presentation of disease,” Lancet Infectious Diseases, vol. 5, no. 3, pp. 174–183, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. C. L. Daley, “Molecular epidemiology: a tool for understanding control of tuberculosis transmission,” Clinics in Chest Medicine, vol. 26, no. 2, pp. 217–231, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Mondragón-Barreto, C. A. Vázquez-Chacón, C. Barrón-Rivero et al., “Comparison among three methods for mycobacteria identification,” Salud Publica de Mexico, vol. 42, no. 6, pp. 484–489, 2000. View at Google Scholar
  18. S. Kulkarni, C. Sola, I. Filliol, N. Rastogi, and G. Kadival, “Spoligotyping of Mycobacterium tuberculosis isolates from patients with pulmonary tuberculosis in Mumbai, India,” Research in Microbiology, vol. 156, no. 4, pp. 588–596, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Kamerbeek, L. Schouls, A. Kolk et al., “Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology,” Journal of Clinical Microbiology, vol. 35, no. 4, pp. 907–914, 1997. View at Google Scholar · View at Scopus
  20. K. Brudey, J. R. Driscoll, L. Rigouts et al., “Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology,” BMC Microbiology, vol. 6, article no. 23, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Sreevatsan, X. Pan, K. E. Stockbauer et al., “Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 18, pp. 9869–9874, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Brosch, S. V. Gordon, M. Marmiesse et al., “A new evolutionary scenario for the Mycobacterium tuberculosis complex,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 6, pp. 3684–3689, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Soini, X. Pan, A. Amin, E. A. Graviss, A. Siddiqui, and J. M. Musser, “Characterization of Mycobacterium tuberculosis isolates from patients in Houston, Texas, by spoligotyping,” Journal of Clinical Microbiology, vol. 38, no. 2, pp. 669–676, 2000. View at Google Scholar · View at Scopus
  24. N. Rastogi and C. Sola, “Molecular evolution of the Mycobacterium tuberculosis complex,” in Tuberculosis, J. C. Palomino, S. Leao, and V. Ritacco, Eds., pp. 53–91, Amedeo Online Textbooks, 2007, http://www.tuberculosistextbook.com/index.htm. View at Google Scholar
  25. Centers for Disease Control and Prevention, “Population-based survey for drug resistance of tuberculosis—Mexico, 1997,” Morbidity and Mortality Weekly Report, vol. 47, pp. 371–375, 1998. View at Google Scholar
  26. J. Sifuentes-Osornio, L. A. Ponce-De-Leon, F. E. Camacho-Mezquita et al., “Drug resistance of M. tuberculosis in Mexican patients. I. Clinical manifestations and risk factors,” Revista de Investigacion Clinica, vol. 47, no. 4, pp. 273–281, 1995. View at Google Scholar · View at Scopus
  27. C. R. Peter, E. Schultz, K. Moser et al., “Drug-resistant pulmonary tuberculosis in the Baja California-San Diego County border population,” Western Journal of Medicine, vol. 169, no. 4, pp. 208–213, 1998. View at Google Scholar · View at Scopus
  28. M. L. García-García, Ma. E. Jiménez-Corona, A. Ponce-De-León et al., “Mycobacterium tuberculosis drug resistance in a suburban community in Southern Mexico,” International Journal of Tuberculosis and Lung Disease, vol. 4, no. 12, supplement 2, pp. S168–S170, 2000. View at Google Scholar
  29. M. L. García-García, A. Ponce-De-León, M. E. Jiménez-Corona et al., “Clinical consequences and transmissibility of drug-resistant tuberculosis in southern Mexico,” Archives of Internal Medicine, vol. 160, no. 5, pp. 630–636, 2000. View at Google Scholar · View at Scopus
  30. Z. H. Yang, A. Rendon, A. Flores et al., “A clinic-based molecular epidemiologic study of tuberculosis in Monterrey, Mexico,” International Journal of Tuberculosis and Lung Disease, vol. 5, no. 4, pp. 313–320, 2001. View at Google Scholar · View at Scopus
  31. M. L. García-García, J. L. Valdespino-Gómez, M. Palacios-Martínez, M. E. Mayar-Maya, C. García-Sancho, and J. Sepúlveda-Amor, “Tuberculosis and AIDS in Mexico,” Salud Pública de México, vol. 37, no. 6, pp. 539–548, 1995. View at Google Scholar · View at Scopus
  32. M. A. Espinal, A. Laszlo, L. Simonsen et al., “Global trends in resistance to antituberculosis drugs,” New England Journal of Medicine, vol. 344, no. 17, pp. 1294–1303, 2001. View at Publisher · View at Google Scholar
  33. M. C. Becerra, J. Bayona, J. Freeman, P. E. Farmer, and J. Y. Kim, “Redefining MDR-TB transmission ‘hot spots’,” International Journal of Tuberculosis and Lung Disease, vol. 4, no. 5, pp. 387–394, 2000. View at Google Scholar · View at Scopus
  34. U. B. Singh, N. Suresh, N. V. Bhanu et al., “Predominant tuberculosis spoligotypes, Delhi, India,” Emerging Infectious Diseases, vol. 10, no. 6, pp. 1138–1142, 2004. View at Google Scholar · View at Scopus
  35. S. Ferdinand, C. Sola, S. Chanteau et al., “A study of spoligotyping-defined Mycobacterium tuberculosis clades in relation to the origin of peopling and the demographic history in Madagascar,” Infection, Genetics and Evolution, vol. 5, no. 4, pp. 340–348, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. S. A. M. Al-Hajoj, T. Zozio, F. Al-Rabiah et al., “First insight into the population structure of Mycobacterium tuberculosis in Saudi Arabia,” Journal of Clinical Microbiology, vol. 45, no. 8, pp. 2467–2473, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Namouchi, A. Karboul, B. Mhenni et al., “Genetic profiling of Mycobacterium tuberculosis in Tunisia: predominance and evidence for the establishment of a few genotypes,” Journal of Medical Microbiology, vol. 57, no. 7, pp. 864–872, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. Z. H. Helal, M. S. E. D. Ashour, S. A. Eissa et al., “Unexpectedly high proportion of ancestral manu genotype Mycobacterium tuberculosis strains cultured from tuberculosis patients in Egypt,” Journal of Clinical Microbiology, vol. 47, no. 9, pp. 2794–2801, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Nava-Aguilera, Y. López-Vidal, E. Harris et al., “Clustering of Mycobacterium tuberculosis cases in Acapulco: spoligotyping and risk factors,” Clinical and Developmental Immunology, vol. 2011, Article ID 408375, 12 pages, 2011. View at Publisher · View at Google Scholar
  40. P. Supply, C. Allix, S. Lesjean et al., “Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis,” Journal of Clinical Microbiology, vol. 44, no. 12, pp. 4498–4510, 2006. View at Publisher · View at Google Scholar · View at Scopus